Pharmacokinetics and Pharmacodynamics of Oral Tapentadol Hydrochloride in Dogs (vol 46, pg E1, 2017)

被引：0

作者：

Howard, James ^{[1
]}

Aarnes, Turi K. ^{[1
]}

Dyce, Jonathan ^{[1
]}

Lerche, Phillip ^{[1
]}

Wulf, Larry W. ^{[2
]}

Coetzee, Johann F. ^{[2
,3
]}

Lakritz, Jeffrey ^{[1
]}

Agnello, Kim ^{[5
]}

Deahl, Lauren ^{[4
]}

Caceres, Ana ^{[5
]}

Ben-Amotz, Ron ^{[4
]}

机构：

[1] Ohio State Univ, Columbus, OH 43210 USA

[2] Iowa State Univ, Coll Vet Med, Pharmacol Analyt Support Team, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA

[3] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA

[4] Vet Specialty & Emergency Ctr, Philadelphia, PA USA

[5] Univ Penn, Philadelphia, PA 19104 USA

来源：

VETERINARY SURGERY | 2018年 / 47卷 / 02期

关键词：

D O I：

10.1111/vsu.12770

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

引用

页码：311 / 311

页数：1

共 50 条

[21] Total synthesis of resolvin E1 (vol 52, pg 2623, 2011)
Allard, Melissa
Barnes, Keith
Chen, Xuemei
Cheung, Yiu-Yin
Duffy, Bryan
Heap, Charles
Inthavongsay, John
Johnson, Matthew
Krishnamoorthy, Ravi
Liu, Xuejin
Manley, Chris
Shan, Zhixing
Steffke, Stephan
Varughese, Deepu
Wang, Ruifang
Wang, Yi
Yang, Qiang
Schwartz, C. E.
TETRAHEDRON LETTERS, 2011, 52 (48) : 6512 - 6512
[22] Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NE06860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist (vol 18, pg 726, 2017)
Brown, W.
Leff, R. L.
Griffin, A.
Hossack, S.
Aubray, R.
Walker, P.
Chiche, D. A.
JOURNAL OF PAIN, 2017, 18 (09): : 1150 - 1151
[23] Ecologically implausible carbon response? (vol 451, pg E1, 2008)
de Vries, Wim
Solberg, Svein
Dobbertin, Matthias
Sterba, Hubert
Laubhann, Daniel
Reinds, Gert Jan
Nabuurs, Gert-Jan
Gundersen, Per
Sutton, Mark A.
NATURE, 2009, 457 (7233) : E8 - E8
[24] Etomidate as an Induction Agent in Sepsis (vol 30, pg e1, 2018)
Devlin, Raymond J.
Kalil, David
CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2018, 30 (04) : XIII - XIII
[25] The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration
Abdel-Aleem, H
Villar, J
Gülmezoglu, AM
Mostafa, SA
Youssef, AA
Shokry, M
Watzer, B
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 108 (01): : 25 - 28
[26] RETRACTION: The Witness Set Constraint (Retraction of Vol 34, art no E1, 2017)
Fortuny, Jordi
JOURNAL OF SEMANTICS, 2017, 34 (02)
[27] Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Oral Resolvin E1-based Therapy in Inflammatory Bowel Disease (IBD): Translating Resolvin E1 Activation of BLT1 in Experimental Models to Healthy Volunteers
Danese, S.
Siegmund, B.
Peyrin-Biroulet, L.
Verstockt, B.
Dubinsky, M.
Newman, R.
Thomas, H.
Guttendorf, R.
Lipper, R.
Steinberg, J.
Paperiello, B.
Jennings, T.
Jordan, D.
Parkinson, J.
Mathias, G.
Sands, B.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1237 - I1237
[28] Inhibition of Corneal Inflammation by the Resolvin E1 (vol 56, pg 2728, 2015)
Lee, Ji-Eun
Sun, Yan
Gjorstrup, Per
Pearlman, Eric
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (10) : 5739 - 5739
[29] Response to "What works with gangs: A breakthrough" (vol 18, pg E1, 2019)
Kennedy, D. M.
CRIMINOLOGY & PUBLIC POLICY, 2019, 18 (02) : 505 - 505
[30] Omission in Annual Reviewers List. (vol 127, pg E1, 2009)
Cetinkaya, Altug
El-Dairi, Mays
Fujikado, Takashi
Gaasterland, Douglas
Harris, Alon
Horton, Jonathan
Kaufman, Herbert
Lutty, Gerard
Maier, Philip
Picaud, Serge
Savini, Giacomo
Schulzer, Michael
Sibert, David
Stalmans, Peter
Williams, Michael
ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (04) : 519 - 519

← 1 2 3 4 5 →